AzTrials
AzTrials

Shoulder Impingement SyndromeEMGNCT06789991

Electromyographic Activity of Posterior Oblique Sling Muscles in Patients With Shoulder Impingement Syndrome

An observational study of Shoulder Impingement Syndrome, run by Cairo University at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

this study aims to assess the gluteus maximus muscle electromyographic activity and the latissimus dorsi muscle electromyographic activity in patients with shoulder impingement syndrome , to improve the assessment procedure and the rehabilitation program for treating patients with shoulder impingement syndrome more… Read more about this study

Who is it for?
Ages 25 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Shoulder Impingement Syndrome
What is being tested?
electromyography
Type of treatment
Medical device
How many people
60 participants
Where
1 siteEgypt
Study dates
Jan 2025to Apr 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: All patients will be referred by an orthopedic surgeon who will diagnose SIS based on clinical and radiological examination.

Who may be able to join

  • Both male and female patients with shoulder impingement syndrome.
  • patients complain from unilateral shoulder pain with chronic conditions of SIS ≥ 3 months.
  • Patient age from 25 to 40 years.
  • Patients with Positive impingement tests.
  • Patients with painful arc of movement (60°- 120°)

Who cannot join

  • Patients with Numbness or tingling of upper extremity.
  • Patients with Shoulder fracture or previous shoulder surgery, and Acromioclavicular or shoulder dislocation.
  • Patients with Any traumatic injury to the lower limb in the previous 6 months.
  • Any spine surgery within the last 2 years.
  • Patients with history of lower back pain in past 12 months .
  • Patients with history of lower extremity dysfunctions in the past 12 months .
Show all 9Show fewer
  • Participants who had taken any drugs (e.g. statins and spasmed), which have effects on the skeletal muscles.
  • Open wounds, rashes, psoriasis, skin irritations, or skin conditions of any kind in the region of electrode placement
  • Participants with a Body Mass Index (BMI) ≥ 30

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

nada M emara, BSc contact

00201005281592

nada.emara@pua.edu.eg

Egypt1 site
  • Cairo University

    Cairo, Giza Governorate, 12613

    Sohier S Rizk, PhD, 0020124003374, sohair.shehata@pt.cu.edu.eg

    Aya A Khalil, PhD, 00201112204944, aya.abdelhamid@pt.cu.edu.eg

Other trials in Egypt

About this study

this study aims to assess the gluteus maximus muscle electromyographic activity and the latissimus dorsi muscle electromyographic activity in patients with shoulder impingement syndrome , to improve the assessment procedure and the rehabilitation program for treating patients with shoulder impingement syndrome more effectively. .

Read the detailed description

background: Shoulder pain is the third most common musculoskeletal complaint that can lead to disability that interfere with work, hobbies, social, and sporting activities and may also be associated with psychological distress and reduced quality of life .Shoulder impingement syndrome Symptoms is the most common cause of shoulder pain.

Normal shoulder movement is achieved through a stable lumbopelvic-hip complex and scapula. Thus, the pelvis must provide a stable platform for the scapula and the scapula provide a stable platform for the shoulder. The existing evidence supports myofascial biomechanical connection between lumbopelvic region and contralateral glenohumeral joint .So Considering the LP region and related myofascial force transmission as contributing factors for shoulder pathogenesis can explain the reasoning on why some of the patients with shoulder pain may progress to develop chronic shoulder pain.

purpose: this study aims to assess the gluteus maximus muscle electromyographic activity and the latissimus dorsi muscle electromyographic activity in patients with shoulder impingement syndrome , to improve the assessment procedure and the rehabilitation program for treating patients with shoulder impingement syndrome more effectively.

methods: This study is a cross sectional comparative study will be conducted at the out-patient physical therapy clinic, Pharos University in Alexandria, Egypt. 30 patients with unilateral shoulder impingement and 30 healthy controls without shoulder impingement , with age range between 25 and 40 years will be included in the study. All patients will be referred by an orthopedic surgeon.

results: data analysis with one-way ANOVA will be used to compare between subjects characteristics of the two groups and un-paired t-test will be used to compare measured variables between groups.

keywords: shoulder impingement syndrome, posterior oblique sling , electromyography , latissimus dorsi , gluteus maximus

Being tested
electromyography
Medical subject headings
Shoulder Impingement Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • electromyographyDevice

    electromyographic activity of posterior oblique sling muscles will be measured

Study groups in NCT06789991
Study groupRoleWhat they receive
Group A (control group)controls
Receives: Device: electromyography
Group B (experimental group)cases
Receives: Device: electromyography

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. • electromyographic activity of posterior oblique sling muscles (gluteus maximus and latissimus dorsi)

    EMG has been widely used for many decades, its use is proven and widely accepted by clinicians and the scientific community and it is considered the gold standard method for the measurement of muscle activity.

    Measured: through study completion, an average of 4 months

Secondary outcomes (3)
  1. shoulder active range of motion

    Universal goniometry is frequently used by physical therapists to assess ROM due to its ease of use, portability, noninvasive nature, and low cost.

    Measured: through study completion, an average of 4 months

  2. shoulder function and disability level

    The Arabic Q-DASH questionnaire has demonstrated good reliability, validity, and responsiveness when used for patients with upper extremity disorders.

    Measured: through study completion, an average of 4 months

  3. shoulder pain

    The ordinal 11-point NPRS (0-no pain, 10-most intense pain) has good test-retest reliability (r=.79-.96) in individuals with chronic pain and musculoskeletal pathology.

    Measured: through study completion, an average of 4 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jan 2025
  2. Study startJan 2025 (estimated)
  3. Primary completionApr 2025 (estimated)
  4. Study completionApr 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06789991
Sponsor's protocol ID
P.T.REC/012/005452
Other IDs
P.T.REC/012/005452
Acronym
EMG
Status last verified
Jan 2025
First submitted
16 Jan 2025
Last updated
23 Jan 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Shoulder Impingement Syndrome, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 23 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact nada M emara, BSc (00201005281592, nada.emara@pua.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

• electromyographic activity of posterior oblique sling muscles (gluteus maximus and latissimus dorsi) (time frame: through study completion, an average of 4 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in